Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Managed Care + Specialty Pharmacy (JMCP)
Although cost savings were observed with 5% weight loss, uncertainty surrounding cost savings accounting for the cost of more recently approved interventions remains.
Clinical Pharmacology September 3rd 2025
Cancer Therapy Advisor
The median post-rebate spending per beneficiary was higher for the low-added-benefit drugs ($70,524) than for the high-added-benefit drugs ($61,277).
Clinical Pharmacology April 29th 2025
Cleveland Clinic Journal of Medicine (CCJM)
“Pulmonary arterial hypertension, a rare [form] of pulmonary hypertension, has a disproportionate impact on women,” wrote investigator Vallerie V. McLaughlin, MD, and co-authors in a published abstract for the study.
Cardiology November 11th 2024